All News

Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth

Biosensors for On-The-Spot Tests: Two Companies Plan to Debut New Tech for Covid-19 Testing by Year's End

U. S. Cities Pilot Connected-Vehicle Tech: Enabling Conventional Vehicles to Communicate Could Save Lives Right Now

Company: New Coronavirus Test Could Diagnose The Virus in 60 Seconds or Less

Barda to Work With Hememics on Rapid Covid-19 Test

Hememics’ Rapid Point-of-Care Covid-19 Test Gets Infusion From Barda

HEMEMICS Biotechnologies, Inc. Receives HHS Support to Develop Rapid Antigen, Antibody Diagnostic to Identify COVID-19 Infected Americans

Inova Personalized Health Accelerator Accepts HeMemics Biotechnologies, Inc. into Portfolio

Hememics Biotechnologies Inc. Received $2.5 Million Investment from AMVI Partners